Brief: Aker BioMarine Q2 Adjusted EBITDA USD 13.6 Million
July 11 (Reuters) - Aker Biomarine ASA AKBM.OL: AKER BIOMARINE Q2 ADJUSTED EBITDA USD 13.6 MILLION AKER BIOMARINE Q2 REVENUE USD 55.3 MILLION AKER BIOMARINE ASA - ACTIVELY ASSESSING POTENTIAL IMPACT OF INCREASED MACROECONOMIC UNCERTAINTY AND NEW TARIFFS Source text: ID:nObifxwJva Further company coverage: AKBM.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million